1.
Peery, AF, Dellon, ES, Lund, J, et al. (2012) Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology
143, 1179–1187.
2.
Fagenholz, PJ, Castillo, CF, Harris, NS, et al. (2007) Increasing United States hospital admissions for acute pancreatitis, 1988–2003. Ann Epidemiol
17, 491–497.
3.
McClave, SA, Martindale, RG, Vanek, VW, et al. (2009) Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN
33, 277–316.
4.
Kreymann, KG, Berger, MM, Deutz, NE, et al. (2006) ESPEN Guidelines on Enteral Nutrition: intensive care. Clin Nutr
25, 210–223.
5.
Braunschweig, CL, Levy, P, Sheean, PM, et al. (2001) Enteral compared with parenteral nutrition: a meta-analysis. Am J Clin Nutr
74, 534–542.
7.
Petrov, MS & Zagainov, VE (2007) Influence of enteral versus parenteral nutrition on blood glucose control in acute pancreatitis: a systematic review. Clin Nutr
26, 514–523.
8.
Petrov, MS, Pylypchuk, RD & Uchugina, AF (2009) A systematic review on the timing of artificial nutrition in acute pancreatitis. Br J Nutr
101, 787–793.
9.
Marik, PE & Zaloga, GP (2004) Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. BMJ
328, 1407.
10.
McClave, SA, Chang, WK, Dhaliwal, R, et al. (2006) Nutrition support in acute pancreatitis: a systematic review of the literature. JPEN
30, 143–156.
11.
Yi, F, Ge, L, Zhao, J, et al. (2012) Meta-analysis: total parenteral nutrition versus total enteral nutrition in predicted severe acute pancreatitis. Intern Med
51, 523–530.
12.
Cao, Y, Xu, Y, Lu, T, et al. (2008) Meta-analysis of enteral nutrition versus total parenteral nutrition in patients with severe acute pancreatitis. Ann Nutr Metab
53, 268–275.
13.
Petrov, MS, van Santvoort, HC, Besselink, MG, et al. (2008) Enteral nutrition and the risk of mortality and infectious complications in patients with severe acute pancreatitis: a meta-analysis of randomized trials. Arch Surg
143, 1111–1117.
14.
Petrov, MS (2013) Nutrition, inflammation, and acute pancreatitis. ISRN Inflamm
2013, 341410.
15.
Windsor, AC, Kanwar, S, Li, AG, et al. (1998) Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut
42, 431–435.
16.
Flint, RS & Windsor, JA (2003) The role of the intestine in the pathophysiology and management of severe acute pancreatitis. HPB
5, 69–85.
17.
Kalfarentzos, F, Kehagias, J, Mead, N, et al. (1997) Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg
84, 1665–1669.
18.
Wu, LM, Sankaran, SJ, Plank, LD, et al. (2014) Meta-analysis of gut barrier dysfunction in patients with acute pancreatitis. Br J Surg
101, 1644–1656.
19.
Demirci, S, Akbal, E, Kocak, E, et al. (2012) Adipokine levels in the course of mild biliary pancreatitis. Ann Nutr Metab
61, 271–274.
20.
Schaffler, A, Landfried, K, Volk, M, et al. (2007) Potential of adipocytokines in predicting peripancreatic necrosis and severity in acute pancreatitis: pilot study. J Gastroenterol Hepatol
22, 326–334.
21.
Feng, Y, Li, Y, Mei, S, et al. (2014) Exclusive enteral nutrition ameliorates mesenteric adipose tissue alterations in patients with active Crohn's disease. Clin Nutr
33, 850–858.
22.
Schaffler, A, Hamer, O, Dickopf, J, et al. (2010) Admission resistin levels predict peripancreatic necrosis and clinical severity in acute pancreatitis. Am J Gastroenterol
105, 2474–2484.
23.
Schaffler, A, Hamer, OW, Dickopf, J, et al. (2011) Admission visfatin levels predict pancreatic and peripancreatic necrosis in acute pancreatitis and correlate with clinical severity. Am J Gastroenterol
106, 957–967.
24.
Tukiainen, E, Kylanpaa, ML, Ebeling, P, et al. (2006) Leptin and adiponectin levels in acute pancreatitis. Pancreas
32, 211–214.
25.
Sharma, A, Muddana, V, Lamb, J, et al. (2009). Low serum adiponectin levels are associated with systemic organ failure in acute pancreatitis. Pancreas
38, 907–912.
26.
Duarte-Rojo, A, Lezama-Barreda, A, Ramirez-Iglesias, MT, et al. (2006) Is leptin related to systemic inflammatory response in acute pancreatitis?
World J Gastroenterol
12, 4392–4396.
27.
Petrov, MS, McIlroy, K, Grayson, L, et al. (2013) Early nasogastric tube feeding versus nil per os in mild to moderate acute pancreatitis: a randomized controlled trial. Clin Nutr
32, 697–703.
28.
Pan, HY, Guo, L & Li, Q (2010) Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diab Res Clin Pract
88, 29–33.
29.
Shibata, R, Ouchi, N, Takahashi, R, et al. (2012) Omentin as a novel biomarker of metabolic risk factors. Diabetol Metab Syndr
4, 37–40.
30.
de Souza Batista, CM, Yang, RZ, Lee, MJ, et al. (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes
56, 1655–1661.
31.
Tan, BK, Pua, S, Syed, F, et al. (2008) Decreased plasma omentin-1 levels in type 1 diabetes mellitus. Diab Med
25, 1254–1255.
32.
Yoo, HJ, Hwang, SY, Hong, HC, et al. (2011) Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol
10, 103–110.
33.
Moreno-Navarrete, JM, Catalan, V, Ortega, F, et al. (2010) Circulating omentin concentration increases after weight loss. Nutr Metab
7, 27–32.
34.
El-Mesallamy, HO, El-Derany, MO & Hamdy, NM (2011) Serum omentin-1 and chemerin levels are interrelated in patients with type 2 diabetes mellitus with or without ischaemic heart disease. Diab Med
28, 1194–1200.
35.
Auguet, T, Quintero, Y, Riesco, D, et al. (2011) New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet
12, 60–67.
36.
Jialal, I, Devaraj, S, Kaur, H, et al. (2013) Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab
98, E514–E517.
37.
Sit, M, Aktas, G, Yilmaz, EE, et al. (2014) Effects of the inflammatory response on serum omentin levels in early acute and chronic pancreatitis. Clin Ter
165, e148–e152.
38.
Kolaczynski, JW, Ohannesian, JP, Considine, RV, et al. (1996) Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab
81, 4162–4165.
39.
Weigle, DS, Duell, PB, Connor, WE, et al. (1997) Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab
82, 561–565.
40.
Konturek, PC, Jaworek, J, Maniatoglou, A, et al. (2002) Leptin modulates the inflammatory response in acute pancreatitis. Digestion
65, 149–160.
41.
Emilsson, V, Liu, YL, Cawthorne, MA, et al. (1997) Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes
46, 313–316.
42.
Poitout, V, Rouault, C, Guerre-Millo, M, et al. (1998) Inhibition of insulin secretion by leptin in normal rodent islets of Langerhans. Endocrinology
139, 822–826.
43.
La Cava, A & Matarese, G (2004) The weight of leptin in immunity. Nat Rev Immunol
4, 371–379.
44.
Petrov, MS & Windsor, JA (2010) Classification of the severity of acute pancreatitis: how many categories make sense?
Am J Gastroenterol
105, 74–76.
45.
Dellinger, E, Forsmark, C, Layer, P, et al. (2012) Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation. Ann Surg
256, 875–880.
